In glioma, PDE2A/miR-139 suppressed Wnt/β-catenin signaling by inhibiting cAMP accumulation and Glycogen Synthase Kinase-3β phosphorylation, thereby modulating the self-renewal of glioma stem cells (84). Here, PDE2A is linked to central nervous system cancer.